Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 116, Issue 1-2, 2009, Pages 86-92

  Hong, Dun ^a,b   Chen, Hai Xiao ^b   Xue, Yun ^a   Li, Dong Mei ^a   Wan, Xiao Chen ^a   Ge, Renshan ^c   Li, Ji Cheng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c POPULATION COUNCIL   (United States)

Author keywords

Dexamethasone; Mesenchymal stem cells; Osteoblastic differentiation; TAZ

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DEXAMETHASONE; TRANSCRIPTIONAL COACTIVATOR WITH PDZ BINDING MOTIF; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, SURFACE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DEXAMETHASONE; GLUCOCORTICOIDS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION; WNT PROTEINS;

RATTUS;

EID: 67449100645     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.05.007     Document Type: Article

References (34)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Makita R., Uchijima Y., Nishiyama K., Amano T., Chen Q., Takeuchi T., Mitani A., Nagase T., Yatomi Y., Aburatani H., Nakagawa O., Small E.V., Cobo-Stark P., Igarashi P., Murakami M., Tominaga J., Sato T., Asano T., Kurihara Y., and Kurihara H. Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. Renal Physiol. 294 (2008) F542-F553
3. Tian Y., Kolb R., Hong J.H., Carroll J., Li D., You J., Bronson R., Yaffe M.B., Zhou J., and Benjamin T. TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex. Mol. Cell. Biol. 27 (2007) 6383-6395
4. Murakami M., Nakagawa M., Olson E.N., and Nakagawa O. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18034-18039
5. Mahoney Jr. W.M., Hong J.H., Yaffe M.B., and Farrance I.K. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388 (2005) 217-225
6. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., and Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309 (2005) 1074-1078
7. Hong J.H., and Yaffe M.B. TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation. Cell Cycle 5 (2006) 176-179
8. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowitz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., and Yaffe M.B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19 (2000) 6778-6791
9. De Biase P., and Capanna R. Clinical applications of BMPs. Injury 36 Suppl. 3 (2005) S43-S46
10. Woolf A.D. An update on glucocorticoid-induced osteoporosis. Curr. Opin. Rheumatol. 19 (2007) 370-375
11. Luppen C.A., Smith E., Spevak L., Boskey A.L., and Frenkel B. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J. Bone Miner. Res. 18 (2003) 1186-1197
12. Canalis E. Mechanisms of glucocorticoid action in bone. Curr. Osteoporos. Rep. 3 (2005) 98-102
13. Jorgensen N.R., Henriksen Z., Sorensen O.H., and Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69 (2004) 219-226
14. Eijken M., Koedam M., van Driel M., Buurman C.J., Pols H.A., and van Leeuwen J.P. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol. Cell. Endocrinol. 248 (2006) 87-93
15. Liu Y., Porta A., Peng X., Gengaro K., Cunningham E.B., Li H., Dominguez L.A., Bellido T., and Christakos S. Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. J. Bone Miner. Res. 19 (2004) 479-490
16. Chen T.L. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 35 (2004) 83-95
17. Atmani H., Chappard D., and Basle M.F. Proliferation and differentiation of osteoblasts and adipocytes in rat bone marrow stromal cell cultures: effects of dexamethasone and calcitriol. J. Cell. Biochem. 89 (2003) 364-372
18. Hong D., Chen H.X., Ge R.S., and Li J.C. The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells. J. Steroid Biochem. Mol. Biol. 111 (2008) 164-170
19. Wan X.C., Liu C.P., Li M., Hong D., Li D.M., Chen H.X., and Li J.C. Staphylococcal enterotoxin C injection in combination with ascorbic acid promotes the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts in vitro. Biochem. Biophys. Res. Commun. 373 (2008) 488-492
20. Meirelles Lda S., and Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 123 (2003) 702-711
21. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
22. Leclerc N., Luppen C.A., Ho V.V., Nagpal S., Hacia J.G., Smith E., and Frenkel B. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J. Mol. Endocrinol. 33 (2004) 175-193
23. Engelbrecht Y., de Wet H., Horsch K., Langeveldt C.R., Hough F.S., and Hulley P.A. Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144 (2003) 412-422
24. Smith E., and Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J. Biol. Chem. 280 (2005) 2388-2394
25. Glass II D.A., and Karsenty G. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. Ann. N.Y. Acad. Sci. 1068 (2006) 117-130
26. Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M., and Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132 (2005) 49-60
27. Yavropoulou M.P., and Yovos J.G. The role of the Wnt signaling pathway in osteoblast commitment and differentiation. Hormones (Athens) 6 (2007) 279-294
28. Glass II D.A., and Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology 148 (2007) 2630-2634
29. Glass II D.A., and Karsenty G. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr. Top. Dev. Biol. 73 (2006) 43-84
30. Gaur T., Lengner C.J., Hovhannisyan H., Bhat R.A., Bodine P.V., Komm B.S., Javed A., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280 (2005) 33132-33140
31. Mbalaviele G., Sheikh S., Stains J.P., Salazar V.S., Cheng S.L., Chen D., and Civitelli R. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J. Cell. Biochem. 94 (2005) 403-418
32. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
33. Liu J., and Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279 (2004) 45020-45027
34. Ohnaka K., Tanabe M., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329 (2005) 177-181